(Total Views: 218)
Posted On: 11/30/2020 8:20:47 AM
Post# of 106

$APRE News Article - Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/apre...91730.html


My Twitter: WhyteStocks